Fate of oral sulphamonomethoxin

S. I. Ashbel; Ашбель С. И.; R. G. Gil; Хиль Р. Г.; V. G. Sokolova; Соколова В. Г.; I. K. Pertsovich; Перцович И. К.

doi:10.17816/kazmj61452

Fate of oral sulphamonomethoxin

Authors: Ashbel S.I.¹, Gil R.G.¹, Sokolova V.G.¹, Pertsovich I.K.¹
Affiliations:
1. Gorky Research Institute of Occupational Hygiene and Diseases
Issue: Vol 52, No 4 (1971)
Pages: 40-41
Section: Articles
URL: https://ogarev-online.ru/kazanmedj/article/view/61452
DOI: https://doi.org/10.17816/kazmj61452
ID: 61452

Cite item

Full Text

Abstract
Full Text
About the authors
References
Supplementary files
Statistics

Abstract

We studied the fate of sulphamonomethoxin in 92 patients in the clinic for infectious and inflammatory diseases of the bronchopulmonary system and the biliary tract. There were 44 men and 48 women. Most of the patients were between the ages of 32 and 55. The patients were each given one tablet of sulfamonomethoxin (0.5 g) and its content in blood, urine, bile and sputum was determined at various intervals by the modified Prebsting and Gavrilov method.